J Gratacós-Masmitjá

Publications (1)8.73 Total impact

• Article: Infliximab in refractory spondyloarthropathies: a multicentre 38 week open study.

  E Collantes-Estévez, M C Muñoz-Villanueva, J D Cañete-Crespillo, R Sanmartí-Sala, J Gratacós-Masmitjá, P Zarco-Montejo, J C Torre-Alonso, C González-Fernández
  Annals of the Rheumatic Diseases 01/2004; 62(12):1239-40. · 8.73 Impact Factor